Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John Herbert Growdon, M.D.

Co-Author

This page shows the publications co-authored by John Growdon and Joseph Locascio.
Connection Strength

1.936
  1. Relation between clinical characteristics of Parkinson's disease and cognitive decline. J Clin Exp Neuropsychol. 2003 Feb; 25(1):94-109.
    View in: PubMed
    Score: 0.274
  2. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies. Neurodegener Dis. 2016; 16(1-2):118-24.
    View in: PubMed
    Score: 0.167
  3. Association between a-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease. Brain. 2015 Sep; 138(Pt 9):2659-71.
    View in: PubMed
    Score: 0.163
  4. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology. 2013 Jan 01; 80(1):85-91.
    View in: PubMed
    Score: 0.136
  5. Brain amyloid and cognition in Lewy body diseases. Mov Disord. 2012 Jul; 27(8):965-73.
    View in: PubMed
    Score: 0.131
  6. Assessing depression and factors possibly associated with depression during the course of Parkinson's disease. Ann Clin Psychiatry. 2011 Aug; 23(3):171-7.
    View in: PubMed
    Score: 0.123
  7. Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers. Alzheimer Dis Assoc Disord. 2010 Jul-Sep; 24(3):220-6.
    View in: PubMed
    Score: 0.114
  8. Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008 Jul-Sep; 22(3):209-21.
    View in: PubMed
    Score: 0.100
  9. Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Arch Neurol. 2008 Jun; 65(6):776-85.
    View in: PubMed
    Score: 0.099
  10. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. Nat Genet. 2021 06; 53(6):787-793.
    View in: PubMed
    Score: 0.061
  11. 18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome. Brain. 2021 02 12; 144(1):266-277.
    View in: PubMed
    Score: 0.060
  12. ß-Glucocerebrosidase activity in GBA-linked Parkinson disease: The type of mutation matters. Neurology. 2020 08 11; 95(6):e685-e696.
    View in: PubMed
    Score: 0.057
  13. Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline. Arch Neurol. 2000 Feb; 57(2):225-32.
    View in: PubMed
    Score: 0.056
  14. The time course of spatial and object learning in Parkinson's disease. Neuropsychologia. 1997 Oct; 35(10):1413-22.
    View in: PubMed
    Score: 0.047
  15. Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases. JAMA Neurol. 2016 Nov 01; 73(11):1334-1341.
    View in: PubMed
    Score: 0.044
  16. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology. 1996 Aug; 47(2):444-8.
    View in: PubMed
    Score: 0.044
  17. Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study. Alzheimers Res Ther. 2014; 6(5-8):52.
    View in: PubMed
    Score: 0.038
  18. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 2013 Oct 22; 81(17):1531-7.
    View in: PubMed
    Score: 0.036
  19. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 2010 Mar-Apr; 51(2):124-9.
    View in: PubMed
    Score: 0.028
  20. Pattern of depressive symptoms in Parkinson's disease. Psychosomatics. 2009 Sep-Oct; 50(5):448-54.
    View in: PubMed
    Score: 0.027
  21. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008 Sep 16; 71(12):903-10.
    View in: PubMed
    Score: 0.025
  22. Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A. 2007 Jan 16; 104(3):955-60.
    View in: PubMed
    Score: 0.022
  23. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology. 2005 Nov 08; 65(9):1402-8.
    View in: PubMed
    Score: 0.021
  24. Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neurodegener Dis. 2005; 2(6):305-12.
    View in: PubMed
    Score: 0.020
  25. Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels. Arch Neurol. 2003 Jul; 60(7):958-64.
    View in: PubMed
    Score: 0.018
  26. Working memory in mild Alzheimer's disease and early Parkinson's disease. Neuropsychology. 2003 Apr; 17(2):230-9.
    View in: PubMed
    Score: 0.017
  27. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol. 1996 Jan; 39(1):62-70.
    View in: PubMed
    Score: 0.010
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.